Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.08% Nasdaq Down 0.83%
Streaming
Ticker Tape: On

Enzon Pharmaceuticals Inc. (ENZN)

-NasdaqGS
1.04 0.06(5.65%) Apr 23, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:0.98
Open:0.99
Bid:0.80 x 500
Ask:1.25 x 300
1y Target Est:14.00
Beta:1.29
Earnings Date:May 5 - May 9 (Est.)
Day's Range:0.98 - 1.04
52wk Range:0.78 - 4.02
Volume:390,690
Avg Vol (3m):539,967
Market Cap:45.86M
P/E (ttm):2.74
EPS (ttm):0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNUp 5.65%45.86M
ISIS4.13B
NKTR1.51B
PFE197.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.26
Ex-Dividend Date:24-Dec-13

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. is engaged in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for Melanoma; Macugen for neovascular age-related macular degeneration; CIMZIA for Crohn’s disea... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback